Taiwan FDA registration c57095b56dbae0178e7a79660be91308
bioMérieux Etest Ceftolozane/Tazobactam
TW: 生物梅里埃易特試梯度條抗生素感受性檢測-Ceftolozane/Tazobactam
Taiwan·Risk Class 2·MD·bioMérieux SA·Registered Nov 27, 2018 – Nov 27, 2023ExpiredRegistration details
- Analysis ID
- c57095b56dbae0178e7a79660be91308
- License Form
- Ministry of Health Medical Device Import No. 031810
- Customs Code
- DHA05603181001
Company information
- Manufacturer
- bioMérieux SA
- Manufacturer Country
- France
- Authorized Representative
- Hong Kong Commercial Mérieux S.p.A. Taiwan Branch
Product details
- Intended Use
- This product is a quantitative detection technique for antibiotic susceptibility, which can be used to determine the minimum inhibitory concentration of gram-negative aerobes (Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoiae, Proteus mirabilis, Pseudomonas aemginosa) in μg/mL.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C1640 Antimicrobial susceptibility test powder
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Nov 27, 2018
- Expiry Date
- Nov 27, 2023
About this record
Access comprehensive regulatory information for bioMérieux Etest Ceftolozane/Tazobactam in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c57095b56dbae0178e7a79660be91308 and manufactured by bioMérieux SA. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices